141 related articles for article (PubMed ID: 3886282)
21. Removal of high-molecular-weight toxins.
Hörl WH
Contrib Nephrol; 1992; 96():138-44. PubMed ID: 1740048
[No Abstract] [Full Text] [Related]
22. Separation and characterization of uremic metabolites in biologic fluids: a screening approach to the definition of uremic toxins.
Gordon A; Berström J; Fürst P; Zimmerman L
Kidney Int Suppl; 1975 Jan; (2):45-51. PubMed ID: 1057692
[No Abstract] [Full Text] [Related]
23. [Biochemical definition of uremia].
Ringoir S
Verh K Acad Geneeskd Belg; 1981; 43(2):105-19. PubMed ID: 7314875
[No Abstract] [Full Text] [Related]
24. Retention patterns.
Schoots A; Vanholder R; Ringoir S; Cramers C
Adv Exp Med Biol; 1987; 223():19-26. PubMed ID: 3447434
[No Abstract] [Full Text] [Related]
25. [Isolation, structure elucidation and synthesis of a hexapeptide from the hemodialysate of uremic patients].
Bovermann G; Rautenstrauch H; Seybold G; Jung G
Hoppe Seylers Z Physiol Chem; 1982 Oct; 363(10):1187-202. PubMed ID: 7141402
[TBL] [Abstract][Full Text] [Related]
26. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
Li G; Chu J; Liu X; Yuan Z
Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
[TBL] [Abstract][Full Text] [Related]
27. Investigations on clinico-chemical correlations in uraemic polyneuritis.
Man NK; Cueuille G; Zingraff J; Drueke T; Jungers P; Sausse A; Billon JP; Funck-Brentano JL
Proc Eur Dial Transplant Assoc; 1975; 11():214-21. PubMed ID: 1197256
[No Abstract] [Full Text] [Related]
28. The synthesis of middle molecular substances in rat tissues: in vitro study.
Dzúrik R; Cernácek P; Spustová V; Válek A
Proc Eur Dial Transplant Assoc; 1978; 15():633-5. PubMed ID: 740703
[No Abstract] [Full Text] [Related]
29. A compound from uremic plasma and from normal urine isolated by liquid chromatography and identified by nuclear magnetic resonance.
Gallice P; Monti JP; Crevat A; Durand C; Murisasco A
Clin Chem; 1985 Jan; 31(1):30-4. PubMed ID: 3965216
[TBL] [Abstract][Full Text] [Related]
30. Middle molecules and the 7 C factor.
Bergström J; Jörnvall H; Zimmerman L
Adv Exp Med Biol; 1987; 223():27-32. PubMed ID: 3447445
[No Abstract] [Full Text] [Related]
31. Preparative isolation of middle molecular weight fractions from the hemofiltrate of patients with chronic uremia.
Brunner H; Mann H; Essers U; Schultheis R; Byrne T; Heintz R
Artif Organs; 1978 Nov; 2(4):375-7. PubMed ID: 743009
[TBL] [Abstract][Full Text] [Related]
32. Middle molecule accumulation in uremia: an "extra uremic factor".
Oulès R; Emond C; Claret G; Branger B; Mion H; Mion C
Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
[TBL] [Abstract][Full Text] [Related]
33. The ultimate salt war? Uraemic toxins are all that count in dialysis patients.
Vanholder R
Nephrol Dial Transplant; 2012 Jan; 27(1):62-6. PubMed ID: 22287703
[No Abstract] [Full Text] [Related]
34. An overview of clinical implications of middle molecules and their kinetics in uremia.
Funck-Brentano JL; Man NK
Artif Organs; 1981; 4 Suppl():125-32. PubMed ID: 7295078
[TBL] [Abstract][Full Text] [Related]
35. [Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography].
Kovalishin IaF; Nikolaev VG; Baran EIa; Dudar' IA; Iushko LA
Vopr Med Khim; 1988; 34(6):23-6. PubMed ID: 3238937
[TBL] [Abstract][Full Text] [Related]
36. Continuous measurement of DTPA-clearance in extracorporeal detoxification circuits.
Falkenhagen D; Ahrenholz P; Roy T; Esther G; Kiencke H; Klinkmann H
Artif Organs; 1981; 4 Suppl():166-8. PubMed ID: 7295085
[TBL] [Abstract][Full Text] [Related]
37. [Study of middle molecules with positive reaction to ninhydrin present in uremic and normal blood and their isolation].
Buzio C; Dall'Aglio PP; Delmonte G; Montagna G; Migone L
Minerva Nefrol; 1979; 26(1):45-8. PubMed ID: 471320
[No Abstract] [Full Text] [Related]
38. The road toward the identification of middle molecules. Preliminary Committee Meeting, Avignon, France November 28-29, 1980.
Bergstrom J; Funck-Brentano JL; Klinkmann H
Artif Organs; 1980 Aug; 4(3):209-10. PubMed ID: 7417037
[No Abstract] [Full Text] [Related]
39. Hippuric acid as a marker.
Vanholder R; Schoots A; Cramers C; De Smet R; Van Landschoot N; Wizemann V; Botella J; Ringoir S
Adv Exp Med Biol; 1987; 223():59-67. PubMed ID: 3447451
[No Abstract] [Full Text] [Related]
40. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
Le Moel G; Strecker G; Cueille G; Boudet J; Man NK; Galli A; Agneray J
Artif Organs; 1981; 4 Suppl():17-21. PubMed ID: 7295087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
